|
⚲
|
| Keyboard |
| Shah Smital
✚
|
|
|---|---|
| CIK # | 0001808821 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001808821] | |
| 4 | [0001808821] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Shah Smital | |
| Lyell Immunopharma Inc | |
| Pliant Therapeutics Inc | |
| LENZ Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Lyell Immunopharma Inc LYEL
Option (right to buy) · derivative
|
2026-03-09 | Grant | 140,000 | $0.00 | |
|
Pliant Therapeutics Inc PLRX
Common Stock (Right to Buy) · derivative
|
2024-06-13 | Grant | 26,764 | $0.00 | |
|
LENZ Therapeutics Inc GRPH
Stock Option (right to buy) · derivative
|
2023-07-19 | Grant | 20,000 | $0.00 | |
|
Pliant Therapeutics Inc PLRX
Stock Option (Right to Buy) · derivative
|
2023-06-07 | Grant | 14,000 | $0.00 | |
|
LENZ Therapeutics Inc GRPH
Stock Option (right to buy) · derivative
|
2022-06-21 | Grant | 20,000 | $0.00 | |
|
Pliant Therapeutics Inc PLRX
Stock Option (right to buy) · derivative
|
2022-06-16 | Grant | 15,000 | $0.00 | |
|
LENZ Therapeutics Inc GRPH
Common Stock
|
2021-06-29 | Buy | 5,882 | $17.00 | 99,994 |
|
Pliant Therapeutics Inc PLRX
Stock Option (right to buy) · derivative
|
2021-06-29 | Grant | 13,286 | $0.00 | |
|
LENZ Therapeutics Inc GRPH
Stock Option (right to buy) · derivative
|
2021-04-15 | Grant | 93,585 | $0.00 |